1. Home
  2. BDSX vs CTW Comparison

BDSX vs CTW Comparison

Compare BDSX & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.29

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

CTW

CTW Cayman Class A Ordinary Shares

HOLD

Current Price

$2.40

Market Cap

125.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
CTW
Founded
2005
2013
Country
United States
Japan
Employees
N/A
N/A
Industry
Precision Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
125.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
CTW
Price
$14.29
$2.40
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.50
N/A
AVG Volume (30 Days)
129.7K
30.5K
Earning Date
05-12-2026
05-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.70
N/A
P/E Ratio
N/A
$22.41
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$1.10
52 Week High
$20.21
$3.14

Technical Indicators

Market Signals
Indicator
BDSX
CTW
Relative Strength Index (RSI) 44.63 66.03
Support Level $6.33 $1.85
Resistance Level $20.21 $2.68
Average True Range (ATR) 1.47 0.26
MACD -0.59 0.04
Stochastic Oscillator 8.80 98.73

Price Performance

Historical Comparison
BDSX
CTW

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About CTW CTW Cayman Class A Ordinary Shares

CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.

Share on Social Networks: